Market Place
Sourcing Support
ViGeneron Gets Rare Pediatric Designation For VG901 Retinitis Trial
08 Jan 2025 //
GLOBENEWSWIRE
ViGeneron Announces FDA Clearance for VG801 mRNA Gene Therapy
18 Dec 2024 //
GLOBENEWSWIRE
ViGeneron Doses First Patient in VG901 Phase 1b Trial
10 Apr 2024 //
GLOBENEWSWIRE
Nature publication reveals highly efficient AAV delivery of large genes
25 Oct 2023 //
GLOBENEWSWIRE
ViGeneron, Daiichi to develop novel gene therapy for prevalent eye diseases
29 Apr 2022 //
BIOSPECTRUMASIA
ViGeneron and Daiichi Sankyo to develop therapy for eye diseases
26 Apr 2022 //
PHARMATIMES
ViGeneron announces follow-on collaboration with Daiichi Sankyo
25 Apr 2022 //
GLOBENEWSWIRE
ViGeneron signs strategic collaboration and option agreement with Regeneron
06 Apr 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.